Labcorp
936 hedge funds and large institutions have $16.5B invested in Labcorp in 2022 Q3 according to their latest regulatory filings, with 79 funds opening new positions, 321 increasing their positions, 353 reducing their positions, and 97 closing their positions.
187% more call options, than puts
Call options by funds: $81M | Put options by funds: $28.2M
1.14% more ownership
Funds ownership: 103.34% → 104.47% (+1.1%)
9% less repeat investments, than reductions
Existing positions increased: 321 | Existing positions reduced: 353
3% less funds holding
Funds holding: 966 → 936 (-30)
14% less capital invested
Capital invested by funds: $19.2B → $16.5B (-$2.71B)
19% less first-time investments, than exits
New positions opened: 79 | Existing positions closed: 97
32% less funds holding in top 10
Funds holding in top 10: 22 → 15 (-7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Amundi
Paris,
France
|
+$69.3M |
| 2 |
Nordea Investment Management
Stockholm,
Sweden
|
+$65.2M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$64.7M |
| 4 |
BlackRock
New York
|
+$60.1M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
+$58.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$193M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$79M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$72.3M |
| 4 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
-$69.1M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$57.8M |
LH Hedge Fund Activity: Q3 2022 in Review
936 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q3 2022, worth a combined $16.5B — down 14% from $19.2B a quarter earlier.
Sellers outnumbered buyers: 97 funds closed out of LH and 79 opened new positions — a net loss of 18 holders — while 353 trimmed existing stakes and 321 added.
The largest buyer was Amundi, adding an estimated $69.3M. The largest seller was T. Rowe Price Associates, cutting an estimated $193M.
- 936 institutional investors held Labcorp (LH) as of Q3 2022, down from 966 in Q2 2022.
- Funds reported $16.5B of Labcorp stock for Q3 2022, down 14% quarter-over-quarter.
- 79 funds opened new Labcorp positions in Q3 2022 and 97 closed out, a net change of -18 holders.
- The largest Labcorp buyer in Q3 2022 was Amundi, an estimated $69.3M added.
- The largest Labcorp seller in Q3 2022 was T. Rowe Price Associates, an estimated $193M sold.
Based on aggregated 13F filings for Q3 2022.